Quick Answer
Evolent Health, Inc. reported Diluted EPS of $5.07 per share (loss) for fiscal year 2025.
Evolent Health, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$5.07 | -525.9% |
| 2024 | -$0.81 | +36.7% |
| 2023 | -$1.28 | -540.0% |
| 2022 | -$0.20 | +54.5% |
| 2021 | -$0.44 | +88.8% |
| 2020 | -$3.94 | -7.4% |
| 2019 | -$3.67 | -290.4% |
| 2017 | -$0.94 | +73.5% |
| 2016 | -$3.55 | -151.2% |
| 2015 | $6.93 | +151.5% |
| 2014 | -$13.46 | -1459.6% |
| 2013 | $0.99 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.24 | +11.1% | +45.5% |
| June 30, 2025 | -$0.44 | -633.3% | +30.2% |
| March 31, 2025 | -$0.63 | -186.4% | -133.3% |
| September 30, 2024 | -$0.27 | +10.0% | -350.0% |
| June 30, 2024 | -$0.06 | +83.8% | +72.7% |
| March 31, 2024 | -$0.22 | +8.3% | +26.7% |
| September 30, 2023 | -$0.30 | -1600.0% | +18.9% |
| June 30, 2023 | -$0.37 | -640.0% | -54.2% |
- Evolent Health, Inc. showed a decrease of -525.9% in Diluted EPS compared to the prior fiscal year.
- Over the 2013–2025 period, Evolent Health, Inc.’s diluted eps has declined by 612.1% (from $0.99 per share to $5.07 per share (loss)).
- The most recent figure is from Evolent Health, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: